down arrow

Welcure Drugs

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE331C01017
  • NSEID:
  • BSEID: 524661
INR
7.77
-0.15 (-1.89%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.16 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Welcure Drugs Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'10
Mar'09
Mar'08
Mar'07
No of Months
12
12
12
12
Profit Before Tax
-1.77
-5.85
-1.89
-0.78
Adjustment
1.56
4.19
1.79
0.96
Changes In working Capital
1.27
1.84
1.48
0.32
Cash Flow after changes in Working Capital
1.05
0.18
1.37
0.50
Cash Flow from Operating Activities
0.97
0.14
1.30
0.39
Cash Flow from Investing Activities
0.19
0.99
0.08
-0.14
Cash Flow from Financing Activities
-1.23
-0.98
-1.43
-0.28
Net Cash Inflow / Outflow
-0.07
0.15
-0.06
-0.03
Opening Cash & Cash Equivalents
0.25
0.10
0.16
0.19
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.18
0.25
0.10
0.16
Compare Cash Flow Results of Welcure Drugs
Markets Mojo
Figures in Rs cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
-17746691
2399.36
-1,77,49,090.00
-739742.70%
Adjustment
15570981
212.2
1,55,70,769.00
7337779.83%
Changes In working Capital
12659364
20.42
1,26,59,344.00
61994826.54%
Cash Flow after changes in Working Capital
10483654
2631.98
1,04,81,023.00
398218.15%
Cash Flow from Operating Activities
9655001
2152.45
96,52,849.00
448458.67%
Cash Flow from Investing Activities
1915677
-2080.52
19,17,757.00
92176.84%
Cash Flow from Financing Activities
-12252719
5.27
-1,22,52,724.00
-232499511.76%
Net Cash Inflow / Outflow
-682041
77.19
-6,82,118.00
-883687.25%
Opening Cash & Cash Equivalents
2525055
304.82
25,24,751.00
828275.76%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
1843014
382.01
18,42,632.00
482351.77%
Cash Flow - Snapshot (Standalone) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is -218.18% vs 450.00% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
-0.13
0.11
-218.18%